Abstract: BACKGROUND: Currently, the cosmetic industry is overwhelmed in keeping up with the safety assessment of the increasing number of new products entering the market. To meet such demand, research centers have explored alternative methods to animal testing and also the large number of volunteers necessary for preclinical and clinical tests. OBJECTIVES: This work describes the human skin ex-vivo model (hOSEC: Human Organotypic Skin Explant Culture) as an alternative to test the effectiveness of cosmetics and demonstrate its viability through cutaneous keratinocytes' proliferative capacity up to 75 days in culture. METHODS: The skin explants obtained from surgeries were cultured in CO 2 -humid incubator. After 1, 7, 30 and 75 days in culture, skin fragments were harvested for analysis with histomorphological exam (HE staining) on all days of follow-up and immunohistochemistry for Ck5/6, Ck10 and Ki-67 only on the 75th day. RESULTS: On the 7th day, the epidermis was perfect in the dermoepidermal junction, showing the viability of the model. On the 30th day, the epidermis was thicker, with fewer layers on the stratum corneum, although the cutaneous structure was unaltered. On the 75th day, the skin became thinner but the dermoepidermal junctions were preserved and epidermal proliferation was maintained. After the 75th day on culture, the skin was similar to normal skin, expressing keratinocytes with Ck5/6 on supra-basal layers; Ck10 on differentiated layers; and viability could be assessed by the positivity of basal cells by Ki-67. CONCLUSION: The hOSEC model seems a good alternative to animal testing; it can be used as a preclinical test analogous to clinical human skin test with similar effectiveness and viability proven by immunohistological analyses.
INTRODUCTION
Side effects caused by pharmaceutical and topical products are of increasing concern for patients, dermatologists and the chemical industry. Chemicals may be hazardous to the skin, inducing cutaneous irritation, burns and allergies. The regulatory guidelines, as proposed by the European Union, require that data on the level of irritancy of new chemicals must be reported. 1 In addition, the irritancy potential of existing substances may need to be re-evaluated if current data are judged to be insuffi cient. Development of new compounds requires their safety assessment for humans and the environment.
A large number of animals, especially rabbits, are still used to test the dermal irritancy of chemical compounds. 2 For ethical reasons, the use of experimental animals for skin irritation studies is not desirable, especially to test cosmetic products. A number of alternative methods to test for skin irritation have been proposed and several were evaluated at the ECVAM (European Centre for the Validation of Alternative Methods) in pre-validation trials, but none has been successfully pre-validated yet. 3 Some of these methods are based on human keratinocyte culture to analyze the metabolism of dimethyl-thiazoldiphenyltetrazolium bromide (MTT) by cellular lactate dehydrogenase (LDH) con-nections or neutral red from preloaded cells [4] [5] [6] However, some disadvantages must be considered, since these analyses have to be made in a short timeframe and using only diluted products or chemicals in culture medium. Additionally, there is no skin resurfacing in these models to permit topical products to be directly applied, as occurs during in vivo testing.
The hOSEC (human organotypic skin explant culture) represents a model that is closer to in vivo human skin, like a 3D human skin model, consisting entirely of melanocytes, Langerhans cells, keratinocytes, and the whole structure of dermal fi broblasts, glycosaminoglycans and collagen, ideal for laboratory testing. Such features became essential for its differentiation from the existing three-dimensional validated models, which are composed only by keratinocytes and fi broblasts on a devitalized extracellular matrix. By presenting an air-liquid interface, the hOSEC system allows the application of creams, ointments and lipid-soluble substances on the horny layer, whereas in a cell culture system it is possible to add substances that are soluble in its medium due to the absence of a stratum corneum. [7] [8] [9] [10] Considering the complete structure of hOSEC as human skin, this model seems appropriate for testing of topical cutaneous products like sunscreen. Some authors have used the hOSEC model to analyze cell migration into the skin after chemical sensitization; others evaluate it through keratinocyte cytotoxicity by measuring the disappearance of keratinocytic RNA, which is visualized using a modified methyl green-pyronine (MGP) staining. [7] [8] [9] [10] Although these studies have demonstrated the viability of this model, in none of them was such viability longer than 3 weeks, and neither was the explanted skin's proliferative capacity.
So, the purpose of this study is to demonstrate the ex vivo model of human skin (hOSEC) as an alternative for sunscreen (sun protection factor -SPF) efficacy tests and demonstrate its viability through cutaneous keratinocytes' proliferative capacity for up to 75 days in culture.
MATERIAL AND METHODS

Human organotypic skin explant culture (hOSEC)
Skin was obtained with the informed consent of patients undergoing either breast or abdomen reduction surgery, in accordance with the ethical guidelines of the Research Ethics Committee of the Clinics Hospital at Ribeirao Preto Medical School, University of Sao Paulo (protocol number 1669/2014).
The explants were cut (1.0 cm 2 ) and cultured on metal grids into standard 6-well plates in contact with culture medium at 37°C in 5% CO 2 humidifi ed air (Figure 1 ). The culture media consist of Dulbecco's Modifi ed Eagle Medium (DMEM) with 10% Fetal Bovine Serum (Sigma-Aldrich, Germany), 1% anti-anti (10.000 units penicillin, 10 mg streptomycin and 25 μg amphotericin B -Sigma-Aldrich, Germany) and 1% L-glutamine (Sigma-Aldrich, Germany). After 1, 7, 30 and 75 days in culture, the explants were harvested, fi xed in formalin, embedded in paraffi n in compliance with histology and immunohistochemistry methods.
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Histology Paraffi ned sections (3.0 μm) were stained with hematoxylin eosin (HE) for histomorphological analysis. Changes in epidermal morphology assessments were followed by qualitative analysis using LEICA ® DM-4000B optical microscope with a LEI-CA ® DFC 280 camera connected to the computer, with LAS ® -Leica Application for capturing images (Leica Microsystems,Germany) software.
Immunohistochemistry
Three-micrometer paraffi ned sections were subjected to antigen retrieval by autoclaving in citrate buffer, pH 6.0, for 5 minutes. Endogenous peroxidase was blocked with 3% hydrogen peroxide in PBS, followed by nonspecifi c blocking with 1% BSA. The sections were incubated with primary antibody in 1% BSA overnight at 4°C. The antibodies used were mouse anti-human Ck5/6 (1:100 dilution), Ck10 (1:100) and Ki-67 (1:100) (Santa Cruz Biotechnology, USA). NovoLink Polymer Detection System Kit (Novocastra Laboratories Ltd, Newcastle Upon Tyne, UK) was used. The color reaction was developed by 3,3 diaminobenzidine tetrahydrochloride (Sigma-Aldrich, Germany). The sections were counterstained with Mayer's hematoxylin and mounted in Entelan (Sigma-Aldrich, Germany). The expression of Ck5/6 (basal cells of epidermis), Ck10 (stratum corneum) and Ki-67 (proliferative keratinocyte) were analyzed qualitatively only on the 75 th day of follow-up. 
RESULTS
Histological evaluation
Histologically, the model showed viability on the 7 th day, as the appearance of the epidermis was similar to that of the 1 st day and it maintained a perfect connection on the dermoepidermal junction. Furthermore, on the 7 th day, the epidermis presented all the strata: basal, spinosum, granulosum and corneum. There were not any changes observed on the dermis. On the 30 th day the epidermis was thicker and with less stratum spinosum, although the cutaneous structure was unaltered and still viable to receive the application of topical products. On the 75 th day, the skin became thinner, but the dermoepidermal junction was unchanged and there was proliferation of the epidermis (Figure 2 ).
Immunohistochemical evaluation
After the 75 th day on culture, the skin at immunohistochemical examination was similar to normal skin, expressing keratinocytes with Ck5/6 on supra-basal layers; Ck10 on upper differentiated layers and presenting viability which could be confi rmed by the positivity of basal cells to Ki-67. (Figure 3 ). 
DISCUSSION
Animal testing for cosmetic products were banned in several countries and the industries in this fi eld suffered serious constraints 8 . Therefore, research centers are attempting to develop alternative methods to animal use.
The hOSEC is a system of human skin in culture medium, which is the closest to in vivo condition because it maintains all skin structure such as melanocytes, Langerhans cells, keratinocytes, and the entire structure of dermal fi broblasts, glycosaminoglycans and collagen 8 . Due to these aspects it seems suitable to evaluate the safety and effi cacy of topical products such as sunscreens for example, 9 besides retaining important elements of in vivo skin, showing signifi cant advantages for in vitro wound healing studies. 10 It was initially described in studies on allergic contact dermatitis, lasting up to 3 weeks in culture. 9 The present study demonstrated cell viability/vitality of human skin fragments in culture for 75 days. The hOSEC model's viability was confi rmed by the maintenance of dermoepidermal junctions and epidermal proliferation, according to histological and immunohistochemical data for Ck5/6, Ck10 and the Ki-67 proliferation marker. Thus, this method is feasible for cosmetic testing up to 75 days. Moreover, its implementation is faster and less expensive than available in vitro systems. However, this model has some limitations, such as the lack of innervation and circulation. Integration of blood vessels or the equivalent has been the subject of extensive research. 11, 12 Communication in the skin is mediated by cytokines, neurotransmitters, hormones, growth factors and eicosanoids, which can be added to the culture medium although cell-to-cell interactions also appear to be necessary. 8 The presence of all epidermal and dermal cellular types, immune cells such lymphocytes, dendritic cells, macrophages, and the conservation of the in vivo structure and physiology has permitted the use of skin explant in a large panel of diseases and processes, including immune diseases, wound healing, extracellular matrix process, ageing, cancer and cosmetic tests. Furthermore, it represents a good tool to understand physiopathology, and the lack of contact with the organism may be compensated by the addition of many substances. It remains the most representative in vitro model of human skin.
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CONCLUSION
The hOSEC model seems a good animal alternative method for safety assessment of cosmetic products for human uses. In addition, it can be regarded as being valid for a pre-clinical test similar to in vivo clinical human skin test because of the maintanance of its viability which was confi rmed by immunohistological analysis.❑
